News from ngm bio A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 14, 2018, 04:00 ET NGM Bio Announces Results From Phase 2 Study Of NGM282 In NASH Patients Demonstrating Clinically Significant Improvements In Liver Histology After 12 Weeks

NGM Bio, a leading biotech company developing a portfolio of clinical-stage product candidates that modulate novel or previously intractable targets...


Mar 12, 2018, 06:00 ET NGM Bio Announces Publication In The Lancet Of Phase 2 Study Of NGM282 In NASH Patients And Upcoming Presentations Of NGM282 NASH Histology Data And NGM282 PSC Data At The International Liver Congress 2018

NGM Bio today announced multiple milestones for NGM282, an experimental medicine for the treatment of NASH. The company confirmed that results from...


Oct 19, 2017, 08:00 ET NGM Bio Provides Update On NGM282 In NASH

NGM Bio, a research-driven biotechnology company that translates powerful biology into transformative medicines, today provided an update on the...


Apr 22, 2017, 10:00 ET NGM Bio Announces NGM282 Dramatically Reduced Liver Fat and Other Biomarkers Associated With Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial

NGM Bio announced that its lead product candidate, NGM282, met the primary endpoint and key secondary endpoints in a Phase 2 trial of patients with...